Earnings Feed
Start Free
Home/Filings/4/0000899243-22-027156
4//SEC Filing

Artal Group S.A. 4

Accession 0000899243-22-027156

CIK 0001062822other
View on SEC.govCompany Profile

Filed

Jul 31, 8:00 PM ET

Accepted

Aug 1, 4:15 PM ET

Size

26.5 KB

Accession

0000899243-22-027156

Insider Transaction Report

Form 4
Period: 2022-08-01
LEXICON PHARMACEUTICALS, INC.LXRX
Artal International Management S.A.
Director10% Owner
Transactions
  • Purchase

    Common Stock

    2022-08-01$2.50/sh+16,173,800$40,434,500→ 48,433,261 total(indirect: See Footnotes)
Holdings

  • Common Stock

    (indirect: See Footnotes)
    3,516,214

  • Common Stock

    (indirect: See Footnotes)
    35,402,689
ARTAL GROUP S A
Director10% Owner
Transactions
  • Purchase

    Common Stock

    2022-08-01$2.50/sh+16,173,800$40,434,500→ 48,433,261 total(indirect: See Footnotes)
Holdings

  • Common Stock

    (indirect: See Footnotes)
    35,402,689

  • Common Stock

    (indirect: See Footnotes)
    3,516,214
ARTAL INTERNATIONAL SCA
Director10% Owner
Transactions
  • Purchase

    Common Stock

    2022-08-01$2.50/sh+16,173,800$40,434,500→ 48,433,261 total(indirect: See Footnotes)
Holdings

  • Common Stock

    (indirect: See Footnotes)
    35,402,689

  • Common Stock

    (indirect: See Footnotes)
    3,516,214
Invus Public Equities Advisors, LLC
Director10% Owner
Transactions
  • Purchase

    Common Stock

    2022-08-01$2.50/sh+16,173,800$40,434,500→ 48,433,261 total(indirect: See Footnotes)
Holdings

  • Common Stock

    (indirect: See Footnotes)
    3,516,214

  • Common Stock

    (indirect: See Footnotes)
    35,402,689
Invus Advisors, L.L.C.
10% Owner
Transactions
  • Purchase

    Common Stock

    2022-08-01$2.50/sh+16,173,800$40,434,500→ 48,433,261 total(indirect: See Footnotes)
Holdings

  • Common Stock

    (indirect: See Footnotes)
    3,516,214

  • Common Stock

    (indirect: See Footnotes)
    35,402,689
WESTEND SA
Director10% Owner
Transactions
  • Purchase

    Common Stock

    2022-08-01$2.50/sh+16,173,800$40,434,500→ 48,433,261 total(indirect: See Footnotes)
Holdings

  • Common Stock

    (indirect: See Footnotes)
    35,402,689

  • Common Stock

    (indirect: See Footnotes)
    3,516,214
Invus Public Equities, LP
Director10% Owner
Transactions
  • Purchase

    Common Stock

    2022-08-01$2.50/sh+16,173,800$40,434,500→ 48,433,261 total(indirect: See Footnotes)
Holdings

  • Common Stock

    (indirect: See Footnotes)
    3,516,214

  • Common Stock

    (indirect: See Footnotes)
    35,402,689
Invus, L.P.
10% Owner
Transactions
  • Purchase

    Common Stock

    2022-08-01$2.50/sh+16,173,800$40,434,500→ 48,433,261 total(indirect: See Footnotes)
Holdings

  • Common Stock

    (indirect: See Footnotes)
    35,402,689

  • Common Stock

    (indirect: See Footnotes)
    3,516,214
Wittouck Amaury
Director10% Owner
Transactions
  • Purchase

    Common Stock

    2022-08-01$2.50/sh+16,173,800$40,434,500→ 48,433,261 total(indirect: See Footnotes)
Holdings

  • Common Stock

    (indirect: See Footnotes)
    35,402,689

  • Common Stock

    (indirect: See Footnotes)
    3,516,214
Stichting Administratiekantoor Westend
Director10% Owner
Transactions
  • Purchase

    Common Stock

    2022-08-01$2.50/sh+16,173,800$40,434,500→ 48,433,261 total(indirect: See Footnotes)
Holdings

  • Common Stock

    (indirect: See Footnotes)
    3,516,214

  • Common Stock

    (indirect: See Footnotes)
    35,402,689
Footnotes (6)
  • [F1]On July 27, 2022, Artal International S.C.A. entered into a purchase agreement with the Issuer pursuant to which Artal International S.C.A. agreed to purchase 16,173,800 shares of common stock, $0.001 par value per share (the "Issuer Common Stock"), of the Issuer at a price of $2.50 per share. The purchase closed on August 1, 2022.
  • [F2]These securities are directly held by Artal International S.C.A.
  • [F3]These securities are directly held by Invus Public Equities, L.P.
  • [F4]These securities are directly held by Invus, L.P.
  • [F5]Invus Public Equities Advisors, LLC is the general partner of Invus Public Equities, L.P., and Invus Advisors, L.L.C. is the general partner of Invus, L.P. The Geneva branch of Artal International S.C.A. is the managing member of Invus Public Equities Advisors, LLC. Artal International S.C.A. is the managing member of Invus Advisors, L.L.C. The managing partner of Artal International S.C.A. is Artal International Management S.A. The parent company of Artal International Management S.A. is Artal Group S.A. The parent company of Artal Group S.A. is Westend S.A. The majority stockholder of Westend S.A. is Stichting Administratiekantoor Westend (the "Stichting"). Mr. Amaury Wittouck is the sole member of the board of the Stichting.
  • [F6]Each of the Reporting Persons (other than to the extent it directly holds securities reported herein) disclaims beneficial ownership of the securities held by the other Reporting Persons, except to the extent of such Reporting Person's pecuniary interest therein, and, pursuant to Rule 16a-1(a)(4) under the Exchange Act, each of the Reporting Persons (other than to the extent it directly holds securities reported herein) states that the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 of the Exchange Act or for any other purpose.

Documents

2 files

Issuer

LEXICON PHARMACEUTICALS, INC.

CIK 0001062822

→
Entity typeother
IncorporatedLuxembourg

Related Parties

1
  • filerCIK 0001053906

Filing Metadata

Form type
4
Filed
Jul 31, 8:00 PM ET
Accepted
Aug 1, 4:15 PM ET
Size
26.5 KB
View on SEC.gov